Production of antibodies in plants: status after twenty years.
about
Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applicationsImmunochemical methods for ochratoxin A detection: a reviewAlgae as protein factories: expression of a human antibody and the respective antigen in the diatom Phaeodactylum tricornutumPlant-made trastuzumab (herceptin) inhibits HER2/Neu+ cell proliferation and retards tumor growthRapid high yield production of different glycoforms of Ebola virus monoclonal antibodyCo-expression of the protease furin in Nicotiana benthamiana leads to efficient processing of latent transforming growth factor-β1 into a biologically active proteinExpression and glycoengineering of functionally active heteromultimeric IgM in plants.Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus.Proteolysis of recombinant proteins in bioengineered plant cellsManufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes.Protein N-glycosylation in eukaryotic microalgae and its impact on the production of nuclear expressed biopharmaceuticals.Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.Identification of Eps15 as antigen recognized by the monoclonal antibodies aa2 and ab52 of the Wuerzburg Hybridoma Library against Drosophila brain.Protection of recombinant mammalian antibodies from development-dependent proteolysis in leaves of Nicotiana benthamiana.On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect.Production of hybrid-IgG/IgA plantibodies with neutralizing activity against Shiga toxin 1.Emerging antibody products and Nicotiana manufacturing.Monomeric IgA can be produced in planta as efficient as IgG, yet receives different N-glycans.Transgenic Production of an Anti HIV Antibody in the Barley EndospermAn Accessory Protease Inhibitor to Increase the Yield and Quality of a Tumour-Targeting mAb in Nicotiana benthamiana LeavesGene Inactivation by CRISPR-Cas9 in Nicotiana tabacum BY-2 Suspension Cells.Reduction of 13 kD prolamins increases recombinant protein yield and recovery rate in rice endospermSite-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants.Antibody proteolysis: a common picture emerging from plants.Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicidesCharacterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori).Efficient Production of a Bioactive Bevacizumab Monoclonal Antibody Using the 2A Self-cleavage Peptide in Transgenic Rice Callus.Production of recombinant immunotherapeutics for anticancer treatment: the role of bioengineering.Transient expression systems for plant-derived biopharmaceuticals.Plant-made pharmaceuticals: leading products and production platforms.Evolution of plant-made pharmaceuticals.Therapeutic application of monoclonal antibodies in cancer: advances and challenges.Trafficking of endoplasmic reticulum-retained recombinant proteins is unpredictable in Arabidopsis thaliana.From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein.Protection of Human Colon Cells from Shiga Toxin by Plant-based Recombinant Secretory IgA.Accumulation of secreted antibodies in plant cell cultures varies according to the isotype, host species and culture conditions.Comparative in vitro and experimental in vivo studies of the anti-epidermal growth factor receptor antibody nimotuzumab and its aglycosylated form produced in transgenic tobacco plants.Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting.Expression systems and species used for transgenic animal bioreactors.Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
P2860
Q26766215-B793AA4E-7579-44E9-A078-9B4DA9F3FCF5Q27023023-5809D63D-F4D8-454E-9464-CB7CE833B9C9Q28742000-482E701D-6402-46D5-878E-18A341A9B432Q28742246-21CE0F44-C81A-41F5-A07D-48D874CF2C0FQ28743509-3B690E07-C7F6-4256-8FDB-0949B1C0776AQ28821869-B868AF8E-AE6D-4247-8485-A60BE342D21BQ30412932-A50705B3-AFE0-4C9F-9D07-3597F2ED1A07Q31154829-572B57ED-B923-4C93-9D93-9F73621C9BE9Q33560054-CAD570FF-E673-4A0F-B141-65A3D882F870Q33757315-F0D8CED6-055A-4B43-A886-64E3AF3B0E63Q34054932-1A34510C-EC27-44F5-91F5-9F8A29A03EB7Q34057785-7BCF1FFD-43B0-472F-9E5C-488D44F2F430Q34113731-ECEECCFE-67F6-4EC2-94A3-722830A369DEQ34875756-7857AE50-BE3B-4B7D-801C-282D579416F6Q35002326-AD727449-6C63-440F-AE01-C8FDA4AFC7AAQ35060348-AB6DD2D0-A1D7-4CEB-A45F-A156C79B43C5Q35194874-674749C7-072B-4B25-80D1-6AC70C0D978FQ35241502-DB1911DC-D17B-40BC-B290-F01AA6C77AF3Q35804905-3616AA3A-B43E-45EE-8253-451F7788F258Q36205638-AE0C1E17-0FF2-4BC8-853B-5F33D1B9F11EQ36524270-55DA0B18-2900-4ED1-87B1-963A4CEA9B82Q36544731-333C565E-F9B0-43BB-8F06-BF145BB7150DQ36705341-7F2058DB-FFBE-46D0-A0F8-3E32A33BDD9FQ36781375-4BDC8737-0497-4722-A8B2-AEA327B4329AQ36785795-E2E71366-2B99-4DFF-BC77-D38FB5678A63Q37138255-9BFEF3C2-680E-4A9B-BCE6-7129799D7308Q37159302-4C5E0F20-D52F-427B-94E4-2C6C6A49B925Q37269115-9E73ACB9-D554-4FC0-B5F4-BED8EC8109B4Q37776717-B548C84E-BB0F-47D4-9820-2FE8E787EABDQ37859060-36B2B931-E4CE-4FBC-9EB7-E8A0A14B2E6DQ37891688-97A7058E-89F4-47C5-BE8F-9C788AB70331Q38057179-E2B4E57B-2CFE-4A98-BE5C-058CE5A83F2CQ38259569-14A6E6A7-E2A0-4367-BC1D-6000A1D0F854Q38696255-642ABFF1-F3BD-42DE-93B0-30B54895E3E6Q38709306-4C08E76E-CAB8-4977-9217-8C41B41CDF9EQ39039076-053891F3-1B5B-4FFD-973A-12DE0647FC62Q39263753-54ECC02F-44EF-4167-967C-802344286541Q39320649-49221A0B-0EAC-4B87-91A5-EED184B5434FQ39468670-97F67D12-E635-4CE5-A2B2-8476856E3C81Q39603076-5AD42DF3-B912-4CA4-B154-A8C108BE97E7
P2860
Production of antibodies in plants: status after twenty years.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Production of antibodies in plants: status after twenty years.
@en
Production of antibodies in plants: status after twenty years.
@nl
type
label
Production of antibodies in plants: status after twenty years.
@en
Production of antibodies in plants: status after twenty years.
@nl
prefLabel
Production of antibodies in plants: status after twenty years.
@en
Production of antibodies in plants: status after twenty years.
@nl
P2860
P1476
Production of antibodies in plants: status after twenty years.
@en
P2093
Catherine Navarre
P2860
P304
P356
10.1111/J.1467-7652.2009.00494.X
P577
2010-02-03T00:00:00Z